All news

Wall Street Zen trims STERIS rating to buy

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Wall Street Zen cut STERIS (NYSE:STE) to "buy" from "strong buy," though the broader analyst consensus stays a "Moderate Buy" with an average price target of $271.33. The company posted quarterly EPS of $2.59, beating estimates, on revenue up 7.3% year over year to

Read original source

STE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.